Hexo | |||||
NEWS | |||||
HEXO Stock Drops Following Analyst Downgrade HEXO (NYSE:HEXO) was hit by an analyst downgrade on Friday. In a research note, investment bank Jefferies Financial Group shifted its ...
| |||||
HEXO Stock Slides After Jefferies Downgrades to Underperform HEXO stock is in the red on Friday after Jefferies analyst Owen Bennett downgraded HEXO Corp (TSX:HEXO) (NYSE:HEXO) to Underperform from ...
| |||||
Buds & Duds: Marijuana stocks fade softly into the weekend; XPhyto gets bump from European deal HEXO Corp (TSE:HEXO) (NYSE:HEXO) shares dipped after the company was downgraded to 'Underperform' with a $1 price target by analysts at ...
| |||||
Technicalities Have Great Worth: HEXO Corp. (HEXO) and Conduent Incorporated (CNDT) In the most recent purchasing and selling session, HEXO Corp. (HEXO)'s share price decreased by 0.00 percent to ratify at $1.44. A sum of 3065507 ...
| |||||
HEXO (NASDAQ:HEXO) Shares Gap Down to $1.47 Shares of HEXO Corp. (NASDAQ:HEXO) gapped down before the market opened on Wednesday . The stock had previously closed at $1.46, but ...
| |||||
Mix and Match Stocks HEXO Corp. (HEXO), US Silica Holdings (SLCA) The recent performance of HEXO Corp. (NYSE:HEXO) stock in the market spoke loud and clear to investors as HEXO saw more than 6.40M shares in ...
| |||||
Where the HEXO Corp. (HEXO) stock Worth Stands, Do you know? HEXO Corp. revealed performance of 15.20% during the period of last 5 trading days and shown last 12 months performance of -76.00%. The stock ...
| |||||
Surprise! Billionaire Money Managers Bought These 4 Pot Stocks in the Fourth Quarter Furthermore, billionaire Jim Simons' Renaissance Technologies acquired nearly 1.4 million shares of HEXO during the fourth quarter, pushing its ...
| |||||
Is It Crazy To Buy Atara Biotherapeutics Inc. (NASDAQ:ATRA) And HEXO Corp. (NYSE:HEXO) The shares of Atara Biotherapeutics Inc. (NASDAQ:ATRA) has been pegged with a rating of Neutral by JP Morgan in its latest research note that was ...
| |||||
Cantor likes Celldex in premarket analyst action Guardant Health (NASDAQ:GH) initiated with Buy rating and $104 (19% upside) price target at Guggenheim. HEXO Corp. (HEXO CN) downgraded to ...
| |||||
See more results | Edit this alert |
You have received this email because you have subscribed to Google Alerts. |
Receive this alert as RSS feed |
Send Feedback |
Tidak ada komentar:
Posting Komentar